URGN
UroGenFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
URGN vs peer average
40/100
URGN vs. peer average (F vs. D)
Grade spread
B 1 · D 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ANIP is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.67B
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
URGN
UroGen
ANIP
ANI
Grade
F
B
Momentum
27
60
Value
41
68
Sentiment
29
50
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ANIP
URGN / ANIP
Grade Position
Below peers
URGN vs. peer average (F vs. D)
40/100
Momentum
27
ANIPValue
41
ANIPSentiment
29
ANIPRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs URGN
ANIP is the first peer returned for this comparison set.